Yoğun Bakımda Diürez ve Aldığı Çıkardığı Takibi Esasları

Authors

Flora Özkalaycı Kaçar

References

Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137-e161. doi:10.1161/CIR.0000000000000509
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-177. doi:10.1093/eurheartj/ehx393
Li L, Zhang Z, Xiong Y, et al. Relationship Between Initial Urine Output and Mortality in Patients Hospitalized in Cardiovascular Intensive Care Units: More Is Not Better. Front Cardiovasc Med. 2022;9:853217. Published 2022 Apr 25. doi:10.3389/fcvm.2022.853217
Jentzer JC, Bihorac A, Brusca SB, et al. Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives [published correction appears in J Am Coll Cardiol. 2021 Jan 5;77(1):107-109]. J Am Coll Cardiol. 2020;76(9):1084-1101. doi:10.1016/j.jacc.2020.06.070
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-c184. doi:10.1159/000339789
Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102(2):203-210. doi:10.1161/01.cir.102.2.
Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43(1):61-67. doi:10.1016/j.jacc.2003.07.031
Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019;139(16):e840-e878. doi:10.1161/CIR.0000000000000664
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2022 May 3;145(18): e1033] [published correction appears in Circulation. 2022 Sep 27;146(13): e185] [published correction appears in Circulation. 2023 Apr 4;147(14): e674]. Circulation. 2022;145(18): e895-e1032. doi:10.1161/CIR.0000000000001063
Faris R, Flather MD, Purcell H, et al. Diuretics for heart failure. Cochrane Database Syst Rev 2006; CD003838.
Felker GM, O'Connor CM, Braunwald E, Heart Failure Clinical Research Network Investigators. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2009; 2:56.
Cooper HA, Dries DL, Davis CE, et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100:1311.
Marino, Paul L. and Kenneth M Sutin. The ICU Book. 3rd ed. Philadelphia, Lippincott Williams & Wilkins, 2007.
Brater DC, Day B, Burdette A, Anderson S. Bumetanide and furosemide in heart failure. Kidney Int. 1984;26(2):183-189. doi:10.1038/ki.1984.153
Brater DC. Update in diuretic therapy: clinical pharmacology. Semin Nephrol. 2011;31(6):483-494. doi:10.1016/j.semnephrol.2011.09.003
Francis GS, Siegal RM, Goldsmith SR, Olivari MT, Levine B, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Int Med 1985; 103: 1±6.
Wilson SC, Richard HS. Use of diuretics in patients with heart failure. Available from: https://www.uptodate.com/contents/use-of-diuretics-in-patients-with-heart-failure?search=Use%20of%20diuretics%20in%20patients%20with%20heart%20failure&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
Wargo KA, Banta WM. A comprehensive review of the loop diuretics: should furosemide be first line?. Ann Pharmacother. 2009;43(11):1836-1847. doi:10.1345/aph.1M177
Müller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life. Eur J Heart Fail. 2003;5(6):793-801. doi:10.1016/s1388-9842(03)00150-8
Howard PA, Dunn MI. Aggressive diuresis for severe heart failure in the elderly. Chest. 2001;119(3):807-810. doi:10.1378/chest.119.3.807
Ören B.Yoğun Bakımda Sıvı Dengesi Takibi. Yoğun Bakım Hemşireliği Dergisi 2016;20(2):98-102
Ören B. Sıvı elektrolit dengesi ve dengesizlikleri. İçinde: Temel Hemşirelik Kavramlar, İlkeler, Uygulamalar. Fatma A.A. editör, 2. baskı. İstanbul Medikal Yayıncılık; 2008. s. 185-200.
P. Cox, Insensible water loss and its assessment in adult patients: a review, Acta Anaesthesiologica Scandinavica 31(8) (1987), 771-776.
Smith J, Robert R (2011). ‘Urine Output’ in Vital Signs for Nurses: An Introduction to Clinical Observations. P:96-114. Blackwell Publishing Ltd.

Pages

159-164

Published

May 3, 2024

License

License

How to Cite

1.
Kaçar FÖ, Candan B. Yoğun Bakımda Diürez ve Aldığı Çıkardığı Takibi Esasları. In: Külahçıoğlu Ş, Altay S, editors. Kardiyoloji Yoğun Bakım [Internet]. Türkiye: Academician Publishing Book DOI Portal; 2024 [cited 2026 Jul. 13]. pp. 159-64. Available from: https://omp35.books.akademisyen.net/index.php/akya/catalog/book/3049/chapter/13132